Vesicular GABA Transporter (solute carrier family 32, member 1, bA122O1.1, GABA and Glycine transporter, hVIAAT, Solute carrier family 32 member 1, Vesicular GABA transporter, Vesicular inhibitory amino acid transporter, VGAT, VIA
Biozol Catalog Number:
USB-V2121-87B-HRP
Supplier Catalog Number:
V2121-87B-HRP
Alternative Catalog Number:
USB-V2121-87B-HRP-100
Manufacturer:
US Biological
Host:
Rabbit
Category:
Antikörper
Application:
IHC, WB
Immunogen:
Vesicular GABA Transporter corresponding to the C-terminus, conjugated to KLH. (Acccession NM_080552.2). Cellular Localization: Cytoplasmic vesicle membrane, Multi-pass membrane protein.
Vesicular GABA transporter (VGAT), the first vesicular amino acid transporter to be molecularly identified, differs in structure from previously cloned vesicular neurotransmitter transporters and defines a novel gene family. VGAT is highly concentrated in the nerve endings of GABAergic neurons in the brain and spinal cord but also in glycinergic nerve endings. In contrast, hippocampal mossy fiber boutons, which are glutamatergic but known to contain GABA, lack VGAT immunoreactivity. Although the great majority of nerve terminals containing GABA or glycine are immunopositive for VGAT, subpopulations of nerve endings rich in GABA or glycine appear to lack the protein. Additional vesicular transporters or alternative modes of release may therefore contribute to the inhibitory neurotransmission mediated by these two amino acids. Applications: Suitable for use in Western Blot and Immunohistochemistry. Other applications not tested. Recommended Dilutions: Optimal dilutions to be determined by the researcher. Positive Control: Rat brain lysate Storage and Stability: Store product at 4C if to be used immediately within two weeks. For long-term storage, aliquot to avoid repeated freezing and thawing and store at -20C. Aliquots are stable at -20C for 12 months after receipt. Dilute required amount only prior to immediate use. Further dilutions can be made in assay buffer. Note: Sodium azide is a potent inhibitor of peroxidase and should not be added to HRP conjugates. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Note: Applications are based on unconjugated antibody.